Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)76653Ketonal forte 100 mg (tbl flm 20x100 mg (fľ.skl.hnedá))25.10.2023R
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7951DAbiraterón Sandoz 1000 mg filmom obalené tablety (tbl flm 30x1000 mg (blis.Al/OPA/Al/PVC))25.10.2023R
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)8838DTulip Plus 10 mg/20 mg (tbl flm 30x10 mg/20 mg (blis.OPA/Al/PVC/Al))25.10.2023R
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)8847DTulip Plus 10 mg/40 mg (tbl flm 90x10 mg/40 mg (blis.OPA/Al/PVC/Al))25.10.2023R
 25.10.2023GlaxoSmithKline (Ireland) Limited (GAG-IE-2)50467Volibris 5 mg filmom obalené tablety (tbl flm 30x5 mg (blis.PVC/PVDC/Al))6.4.2023O
 25.10.2023GlaxoSmithKline Biologicals S.A. (GAG)28654Priorix (plv isl 10x0,5 ml+10x0,5 ml solv. (liek.inj.skl.+striek.inj.skl.napl.s 2 oddel.ihlami))25.10.2023R
 25.10.2023Sandoz GmbH (SAN-A)5734BAripiprazole Sandoz 10 mg tablety (tbl 30x10 mg (blis.Al/Al))25.10.2023O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-4)90197Aclasta 5 mg infúzny roztok (sol inf 1x100 ml/5 mg (fľ.plast.))25.10.2023O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)0148AAMIRAP 10 mg/10 mg tvrdé kapsuly (cps dur 30x10 mg/10 mg (blis.Al/OPA/Al/PVC))25.10.2023O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)0218AAMIRAP 5 mg/5 mg tvrdé kapsuly (cps dur 30x5 mg/5 mg (blis.Al/OPA/Al/PVC))25.10.2023O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)13906Levetiracetam Sandoz 1000 mg filmom obalené tablety (tbl flm 100x1000 mg (blis.OPA/Al/PVC/Al))25.10.2023O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)36590FLEKAINID SANDOZ 100 mg tablety (tbl 30x100 mg (bli.Al/PVC/PVDc))25.10.2023O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)38291Fentanyl Sandoz 25 µg/h matrix transdermálna náplasť (emp tdm 5x25 µg/1 h)25.10.2023O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)38295Fentanyl Sandoz 50 µg/h matrix transdermálna náplasť (emp tdm 5x50 µg/1 h)25.10.2023O
 25.10.2023Sandoz Pharmaceuticals d.d. (SAN-SLO-1)4501CFebuxostat Sandoz 120 mg (tbl flm 28x120 mg (blis.Al/PVC/PE/PVDC))26.10.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)